Back to BARCLAYS PLC BARCLAYS PLC

EFTREFTR
5 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in eFFECTOR Therapeutics, Inc.

BARCLAYS PLC previously held 0 shares of EFTR (eFFECTOR Therapeutics, Inc.), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$49

Total Shares Change

-82

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.04
0
2024-Q3
Unchanged
100
0.0%
$40.0%$0.04
0
2024-Q2
New
100
-
$290.0%$0.29
17
2023-Q4
Exited
0
-100.0%
$00.0%$11.69
0
2023-Q3
New
82
-
$490.0%$15.00
17

Other major holders of EFTR: Blackstone Inc., Carlyle Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used